• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chronic perigraft seromas in PTFE grafts.

作者信息

Borrero E, Doscher W

机构信息

Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, New York 11042.

出版信息

J Cardiovasc Surg (Torino). 1988 Jan-Feb;29(1):46-9.

PMID:3339078
Abstract

Well known complications of polytetrafluoroethylene (PTFE) grafts include thrombosis, infection, and pseudoaneurysms. Chronic perigraft seromas (CPS) associated with knitted dacron grafts are well described but only sporadic cases have been described in conjunction with PTFE grafts. In order to document the clinical history of PTFE associated CPS, 1674 PTFE grafts placed during the period from December 1982 through December 1984 were evaluated for the presence of CPS. Eight CPS were documented. All CPS developed in the subcutaneous location of the PTFE graft. Biochemical analysis of the seroma fluid and pathological findings implicate the source of the contents as being due to a local defect in the PTFE graft. CPS can make angioaccess difficult, cause discomfort by mass effect, and as in two patients, occlude a graft. Non-operative therapy was ineffective. Removal of the contents and as much of the pseudocapsule as possible was effective with only a single small recurrence.

摘要

相似文献

1
Chronic perigraft seromas in PTFE grafts.
J Cardiovasc Surg (Torino). 1988 Jan-Feb;29(1):46-9.
2
Effective treatment for recurrent perigraft seromas of upper arm polytetrafluoroethylene grafts: report of two cases.上臂聚四氟乙烯移植物复发性移植周围血清肿的有效治疗:2例报告
Chang Gung Med J. 2003 Jun;26(6):440-3.
3
[Dacron and polytetrafluoroethylene aorto-bifemoral grafts].[涤纶和聚四氟乙烯主动脉-双股动脉移植血管]
Srp Arh Celok Lek. 1997 Mar-Apr;125(3-4):75-83.
4
Partial replacement of an infected arterial graft by a new prosthetic polytetrafluoroethylene segment: a new therapeutic option.用新的聚四氟乙烯人工血管段部分替换感染的动脉移植物:一种新的治疗选择。
J Vasc Surg. 1993 Mar;17(3):546-58.
5
Acute perigraft seroma simulating anastomotic bleeding of a PTFE graft applied as an arteriovenous shunt for hemodialysis.
Ann Vasc Surg. 1996 May;10(3):290-1. doi: 10.1007/BF02001895.
6
The Potential Relation Between polytetrafluoroethylene Grafts after Open Reconstructions for Abdominal Aortic Aneurysm and Perigraft Seromas.开放式腹主动脉瘤重建术后聚四氟乙烯移植物与包裹性血清肿之间的潜在关系。
Ann Vasc Surg. 2021 Jan;70:444-448. doi: 10.1016/j.avsg.2020.06.025. Epub 2020 Jun 24.
7
Collagen versus gelatin-coated Dacron versus stretch polytetrafluoroethylene in abdominal aortic bifurcation graft surgery: results of a seven-year prospective, randomized multicenter trial.腹主动脉分叉移植手术中胶原蛋白涂层涤纶与明胶涂层涤纶及拉伸聚四氟乙烯的比较:一项为期七年的前瞻性随机多中心试验结果
Surgery. 2001 Sep;130(3):408-14. doi: 10.1067/msy.2001.115904.
8
Perigraft seroma: clinical, histologic, and serologic correlates.
Am J Surg. 1987 Aug;154(2):173-8. doi: 10.1016/0002-9610(87)90173-5.
9
Large perigraft seroma after aortoiliac bypass with an expanded polytetrafluoroethylene graft: report of a case.采用膨体聚四氟乙烯人工血管行主髂动脉搭桥术后出现巨大移植血管周围血清肿:病例报告
Surg Today. 2004;34(8):698-700. doi: 10.1007/s00595-004-2790-9.
10
Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.明胶密封的涤纶移植物并不比聚四氟乙烯移植物更容易受到耐甲氧西林金黄色葡萄球菌(MRSA)感染。
Eur J Vasc Endovasc Surg. 2006 Oct;32(4):425-30. doi: 10.1016/j.ejvs.2006.03.014. Epub 2006 May 24.

引用本文的文献

1
Giant Perigraft Seroma after Axillobifemoral Bypass for Leriche's Syndrome: A Case Report.腋股动脉旁路移植术治疗勒里什综合征后巨大移植周围血清肿:一例报告
Ann Vasc Dis. 2016;9(3):252-254. doi: 10.3400/avd.cr.16-00052. Epub 2016 Aug 31.
2
Slowly developing perigraft seroma after a modified Blalock-Taussig shunt.
Pediatr Cardiol. 2003 Jul-Aug;24(4):412-4. doi: 10.1007/s00246-002-0373-3. Epub 2003 Jan 15.